- Home
- EXAS vs PAG Comparison
EXAS vs PAG Comparison
Compare EXAS & PAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- PAG
- Stock Information
- Founded
- EXAS 1995
- PAG 1990
- Country
- EXAS United States
- PAG United States
- Employees
- EXAS N/A
- PAG N/A
- Industry
- EXAS Medical Specialities
- PAG Retail-Auto Dealers and Gas Stations
- Sector
- EXAS Health Care
- PAG Consumer Discretionary
- Exchange
- EXAS Nasdaq
- PAG Nasdaq
- Market Cap
- EXAS 11.0B
- PAG 11.2B
- IPO Year
- EXAS N/A
- PAG 1996
- Fundamental
- Price
- EXAS $64.82
- PAG $165.89
- Analyst Decision
- EXAS Strong Buy
- PAG Strong Buy
- Analyst Count
- EXAS 21
- PAG 7
- Target Price
- EXAS $69.24
- PAG $183.00
- AVG Volume (30 Days)
- EXAS 2.0M
- PAG 257.3K
- Earning Date
- EXAS 11-03-2025
- PAG 10-29-2025
- Dividend Yield
- EXAS N/A
- PAG 3.20%
- EPS Growth
- EXAS N/A
- PAG 5.84
- EPS
- EXAS N/A
- PAG 14.36
- Revenue
- EXAS $2,939,949,000.00
- PAG $30,577,500,000.00
- Revenue This Year
- EXAS $16.68
- PAG $2.20
- Revenue Next Year
- EXAS $12.12
- PAG $3.61
- P/E Ratio
- EXAS N/A
- PAG $11.47
- Revenue Growth
- EXAS 12.55
- PAG 2.39
- 52 Week Low
- EXAS $38.81
- PAG $134.05
- 52 Week High
- EXAS $72.83
- PAG $189.51
- Technical
- Relative Strength Index (RSI)
- EXAS 81.05
- PAG 37.65
- Support Level
- EXAS $63.05
- PAG $163.57
- Resistance Level
- EXAS $62.31
- PAG $172.19
- Average True Range (ATR)
- EXAS 1.57
- PAG 3.53
- MACD
- EXAS 0.27
- PAG -0.10
- Stochastic Oscillator
- EXAS 92.60
- PAG 17.70
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About PAG Penske Automotive Group Inc.
Penske Automotive Group operates in 19 US states and overseas. It has over 150 US and Puerto Rico light-vehicle stores as well as 210 franchised dealerships overseas, primarily in the United Kingdom but also in Australia, Germany, Italy, and Japan. The company is the third-largest US publicly traded dealership in terms of light-vehicle revenue and sells more than 40 brands, with over 90% of retail automotive revenue coming from luxury and import names. Other segments are service and finance and insurance. The firm's Premier Truck Group owns 45 truck dealerships selling mostly Freightliner and Western Star brands, and Penske owns 16 used-vehicle stores, mostly in the US and UK under the CarShop (US) and Sytner Select (UK) brands. Penske is based in Bloomfield Hills, Michigan.